By clicking on the image, you can see a map of the interactions between the SAAB players.
The Bioproduction Biotherapies Integrators Network: a strategic lever for biotherapies in France
The Bioproduction Biotherapies Integrators Network is part of the national ‘Biotherapies – Bioproduction of Innovative Therapies’ (SABB) strategy, consolidating the French biotherapies ecosystem and accelerating medical and industrial innovation.
Key players and partnerships :
- PEPR Biotherapies and Bioproduction of Innovative Therapies (PEPR-BBTI): Programme targeting technological advances to position France as a European leader.
- COMBIO: Consortium bringing together research bodies (CEA, CNRS, Inserm), universities, university teaching hospitals and technology transfer structures, to accelerate the transfer of innovations to the socio-economic sector.
- France BioLead: Accelerator structuring the French biomanufacturing sector and promoting its international visibility.
Missions and impact:
In synergy with these players, the Integrators Network :
- Consolidates the biotherapy ecosystem by bringing together public, private and industrial players.
- Accelerates the development of innovations, from research to production.
- Strengthens French competitiveness and patient access to innovative treatments.
→ This network plays a key role in France’s strategic autonomy in biotherapies, supporting research, production and technology transfer.